|
Market Closed -
Nasdaq Stockholm
15:30:00 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.090 SEK | -1.42% |
|
+8.40% | +6.09% |
| 10-27 | Irlab Therapeutics Set to Obtain US Patent for Parkinson's Disease Drug Candidate | MT |
| 10-27 | Irlab receives positive patent notice in the US for IRL1117 | FW |
Chart: Technical Analysis
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| IRLAB A | Delayed | |
Deutsche Boerse AG
| 6IRA | Delayed | |
|
OTC Markets
| IRLAF | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 2.12 | 2.12 | 2.32 |
| Spread/Res. | -1.42% | -1.42% | -9.91% |
| Spread/Supp. | +8.40% | +32.28% | +71.31% |
| Support | 1.928 | 1.58 | 1.22 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IRLAB A Stock
- Charts IRLAB Therapeutics AB
Select your edition
All financial news and data tailored to specific country editions
